This Foot Locker Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
Author: Avi Kapoor | May 16, 2025 11:29am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Barclays analyst Adrienne Yih downgraded the rating for Foot Locker, Inc. (NYSE:FL) from Overweight to Equal-Weight and raised the price target from $14 to $24. Foot Locker shares closed at $23.90 on Thursday. See how other analysts view this stock.
UBS analyst David Dai downgraded Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) from Buy to Neutral and lowered the price target from $17 to $2. Iovance Biotherapeutics shares closed at $1.76 on Thursday. See how other analysts view this stock.
Baird analyst Joel Beatty downgraded Neurogene Inc. (NASDAQ:NGNE) from Outperform to Neutral and slashed the price target from $38 to $24. Neurogene shares closed at $19.37 on Thursday. See how other analysts view this stock.
Considering buying FL stock? Here’s what analysts think:
